Hong Wu
Professor
 Molecular & Medical Pharmacology
University of California los Angeles
United States of America
Biography
Dr. Hong Wu is David Geffen Endowed Professor of Molecular Medicine, Professor of Molecular and Medical Pharmacology, Director of Institute for Molecular Medicine and co-Associate Director of the Genitourinary Oncology Program Area of the Jonsson Comprehensive Cancer Center. She also serves as the Director of UCLA ES cell and Transgenic Mice Shared Resource. Dr. Wu received her M.D. degree from Beijing Medical College, China, and her Ph.D. degree in biological chemistry from Harvard Medical School, working with Rudolf Jaenisch at the Whitehead Institute for Biomedical Research.
Research Interest
She was a Damon Runyon-Walter Winchell postdoctoral fellow with Harvey Lodish at the Whitehead Institute for Biomedical Research, MIT. Her laboratory studies the signal transduction pathways controlled by the PTEN tumor suppressor gene, using various genetically engineered animal tumor models.
Publications
-
Ruscetti, Marcus and Wu, Hong PTEN and Prostate Cancer, In D.J. Tindall's Book "Prostate Cancer: Biochemistry, Molecular Biology, and Genetics, Protein Reviews", 2013; (Chapter 4): 87-137.
-
Smith Kathleen B, Tran Linh M, Tam Brenna M, Shurell Elizabeth M, Li Yunfeng, Braas Daniel, Tap William D, Christofk Heather R, Dry Sarah M, Eilber Fritz C, Wu Hong Novel dedifferentiated liposarcoma xenograft models reveal PTEN down-regulation as a malignant signature and response to PI3K pathway inhibition The American journal of pathology, 2013; 182(4): 1400-11.
-
Donahue, T., Tran, L., Wu, H., Toste, P., Wu, N., Wong, J., Li, X., Dawson, D., Wu, X., and Malkhassian, D Endoscopically Acquired Pancreatic Cyst Fluid MicroRNA 21 and 221 are associated with Invasive Cancer , American Journal of Gastroenterology, 2013; .
